The patients with obesity taking colchicine had lower levels of C5a and C9 as compared to patients with obesity under placebo, and complement activation was observed in the endothelium of the subcutaneous adipose tissue associated with the presence of the virus. The gene discussed is C9; the disease is obesity disorder.